PI5P4Ks-IN-2

CAS No. 2766854-03-7

PI5P4Ks-IN-2( —— )

Catalog No. M36403 CAS No. 2766854-03-7

PI5P4Ks-IN-2 is an inhibitor of the phosphatidylinositol 5-phosphate 4-kinase PI5P4Kγ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 370 In Stock
5MG 337 In Stock
10MG 503 In Stock
25MG 848 In Stock
50MG 1088 In Stock
100MG 1423 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PI5P4Ks-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    PI5P4Ks-IN-2 is an inhibitor of the phosphatidylinositol 5-phosphate 4-kinase PI5P4Kγ.
  • Description
    PI5P4Ks-IN-2 is a inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ). PI5P4Ks-IN-2 targets to PI5P4K isoforms with pIC50 values of <4.3 (PI5P4Kα), <4.6 (PI5P4Kβ), 6.2 (PI5P4Kγ), 0.32 (PI5P4Kγ+), respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2766854-03-7
  • Formula Weight
    357.45
  • Molecular Formula
    C22H23N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(CC1=CC=CC=N1)C2=C3C(=NC(=N2)C4=C(C(C)C)C=CC=C4)C=CN3C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Boffey HK, et al. Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode. J Med Chem. 2022 Feb 24;65(4):3359-3370. ?
molnova catalog
related products
  • ZSTK-474

    A potent inhibitor of class I PI3K isoforms with IC50 of 17 nM, 53 nM, and 6 nM for p110β, p110γ, and p110δ, respectively.

  • TASP0415914

    TASP0415914 is an orally potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ).

  • NSC5844

    NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.